Fentanyl mixed with medetomidine
What happened
- Whatcom County, WA warned its fentanyl supply is being adulterated with medetomidine, a non-opioid sedative naloxone doesn't reverse. - Local officials linked the additive to recent overdoses and reports of prolonged withdrawal or sedation. - Naloxone remains essential for the opioid component, but crews should expect mixed toxidromes and prolonged monitoring needs (mynorthwest.com)
Why it matters
Whatcom County, Washington, is warning that fentanyl in the local drug supply may now be mixed with medetomidine, a sedative naloxone does not reverse. (whatcomcounty.org) The county’s provider alert was posted April 17, 2026, after the Centers for Disease Control and Prevention issued a national Health Alert Network notice on April 2 about rising medetomidine detections in fentanyl. (whatcomcounty.org) (cdc.gov) Medetomidine is a veterinary sedative, not an opioid and not approved for human use. In overdose, it can cause extreme sedation, slow heart rate, and low blood pressure. (cdc.gov) (whatcomcounty.org) Naloxone still matters because fentanyl is involved in many of these overdoses, and the immediate goal is to restore breathing. But a person exposed to medetomidine may stay heavily sedated after naloxone because the sedative part of the overdose is still active. (cdc.gov) (whatcomcounty.org) The other risk comes later. People who use medetomidine regularly and then stop can develop severe withdrawal, with high blood pressure, anxiety, nausea, vomiting, confusion, and swings in alertness that can require emergency or intensive care. (cdc.gov 1) (cdc.gov 2) Federal officials say medetomidine first showed up in the fentanyl supply in 2021, then accelerated sharply: reports to the National Forensic Laboratory Information System rose from 247 in 2023 to 2,616 in 2024 and 8,233 in 2025. (cdc.gov) The West still trails other regions, but it is no longer untouched. The Centers for Disease Control and Prevention said all five western sentinel sites detected medetomidine in opioid-positive samples in late 2025, though at lower levels than the Northeast and Midwest. (cdc.gov) Washington’s own drug-checking data shows medetomidine began appearing in the state supply in 2025, often in samples that also contained fentanyl. The University of Washington’s Addictions, Drug & Alcohol Institute says the drug may be showing up as a replacement for xylazine or alongside it. (adai.washington.edu) The Centers for Disease Control and Prevention said testing of seized drugs and clinical samples points to clandestine synthesis, not diversion from veterinary clinics, because the illicit material contains a racemic mix unlike pharmaceutical-grade products. (cdc.gov) Whatcom County told clinicians, first responders, and service providers to watch for overdoses with prolonged sedation and for withdrawal that looks out of proportion to fentanyl alone. The county also asked providers to report suspected cases to its public health line as local officials track whether the sedative is taking hold in the region. (whatcomcounty.org)
Key numbers
- (whatcomcounty.org) The county’s provider alert was posted April 17, 2026, after the Centers for Disease Control and Prevention issued a national Health Alert Network notice on April 2 about rising medetomidine detections in fentanyl.
- (cdc.gov 1) (cdc.gov 2) Federal officials say medetomidine first showed up in the fentanyl supply in 2021, then accelerated sharply: reports to the National Forensic Laboratory Information System rose from 247 in 2023 to 2,616 in 2024 and 8,233 in 2025.
- The Centers for Disease Control and Prevention said all five western sentinel sites detected medetomidine in opioid-positive samples in late 2025, though at lower levels than the Northeast and Midwest.
- (cdc.gov) Washington’s own drug-checking data shows medetomidine began appearing in the state supply in 2025, often in samples that also contained fentanyl.
What happens next
- Whatcom County, Washington, is warning that fentanyl in the local drug supply may now be mixed with medetomidine, a sedative naloxone does not reverse.
- But a person exposed to medetomidine may stay heavily sedated after naloxone because the sedative part of the overdose is still active.
- The University of Washington’s Addictions, Drug & Alcohol Institute says the drug may be showing up as a replacement for xylazine or alongside it.
Quick answers
What happened in Fentanyl mixed with medetomidine?
Whatcom County, WA warned its fentanyl supply is being adulterated with medetomidine, a non-opioid sedative naloxone doesn't reverse. Local officials linked the additive to recent overdoses and reports of prolonged withdrawal or sedation. Naloxone remains essential for the opioid component, but crews should expect mixed toxidromes and prolonged monitoring needs (mynorthwest.com)
Why does Fentanyl mixed with medetomidine matter?
Whatcom County, Washington, is warning that fentanyl in the local drug supply may now be mixed with medetomidine, a sedative naloxone does not reverse. (whatcomcounty.org) The county’s provider alert was posted April 17, 2026, after the Centers for Disease Control and Prevention issued a national Health Alert Network notice on April 2 about rising medetomidine detections in fentanyl. (whatcomcounty.org) (cdc.gov) Medetomidine is a veterinary sedative, not an opioid and not approved for human use. In overdose, it can cause extreme sedation, slow heart rate, and low blood pressure. (cdc.gov) (whatcomcounty.org) Naloxone still matters because fentanyl is involved in many of these overdoses, and the immediate goal is to restore breathing. But a person exposed to medetomidine may stay heavily sedated after naloxone because the sedative part of the overdose is still active. (cdc.gov) (whatcomcounty.org) The other risk comes later. People who use medetomidine regularly and then stop can develop severe withdrawal, with high blood pressure, anxiety, nausea, vomiting, confusion, and swings in alertness that can require emergency or intensive care. (cdc.gov 1) (cdc.gov 2) Federal officials say medetomidine first showed up in the fentanyl supply in 2021, then accelerated sharply: reports to the National Forensic Laboratory Information System rose from 247 in 2023 to 2,616 in 2024 and 8,233 in 2025. (cdc.gov) The West still trails other regions, but it is no longer untouched. The Centers for Disease Control and Prevention said all five western sentinel sites detected medetomidine in opioid-positive samples in late 2025, though at lower levels than the Northeast and Midwest. (cdc.gov) Washington’s own drug-checking data shows medetomidine began appearing in the state supply in 2025, often in samples that also contained fentanyl. The University of Washington’s Addictions, Drug & Alcohol Institute says the drug may be showing up as a replacement for xylazine or alongside it. (adai.washington.edu) The Centers for Disease Control and Prevention said testing of seized drugs and clinical samples points to clandestine synthesis, not diversion from veterinary clinics, because the illicit material contains a racemic mix unlike pharmaceutical-grade products. (cdc.gov) Whatcom County told clinicians, first responders, and service providers to watch for overdoses with prolonged sedation and for withdrawal that looks out of proportion to fentanyl alone. The county also asked providers to report suspected cases to its public health line as local officials track whether the sedative is taking hold in the region. (whatcomcounty.org)
